Comparison of the Effect of Helicobacter Pylori Eradication Before and After the Training of Gastroenterologists

Helicobacter Pylori Infection Clinical Trial

Official title:

Comparison of the Effect of Helicobacter Pylori Eradication Before and After the Training of Gastroenterologists on Standardized Helicobacter Pylori Eradication Therapy

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04984382
• Other study ID #: 2021SDU-QILU-G004
• Status: Recruiting
• Phase: N/A
• Start date: July 26, 2021
• Est. completion date: September 2022

Study information

• Verified date: November 2021
• Source: Shandong University
• Contact: Xiuli Zuo, MD, PhD
• Phone: 86 15588818685
• Email: zuoxiuli[@]sdu.edu.cn
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The researchers recruited gastroenterologists. Physician subjects recruited Helicobacter pylori-positive patients before and after receiving standardized training on Helicobacter pylori eradication. There are no restrictions on treatment options and drugs during the trial. Compare the eradication rate, adverse reaction rate, and patient compliance before and after physician training.

Description:

The researchers recruited gastroenterologists to participate in the study, and gastroenterologists recruited Helicobacter pylori-positive patients. In this process, the patient population is not limited, and the eradication program is not limited. Gastroenterologists can follow up or not follow up according to their original diagnosis and treatment. Researchers follow up and record the patient's medication status and adverse reactions in the medication process by phone or WeChat, and evaluate patient compliance. Record the eradication rate. After waiting for all patients admitted by gastroenterologists to be eradicated and re-examined, we will provide standardized Helicobacter pylori eradication training for gastroenterologist subjects. After the training, gastroenterologists recruit Helicobacter pylori-positive patients here. In this process, the patient population is not limited, and the eradication program is not limited. Gastroenterologists can follow up or not follow up according to their original diagnosis and treatment. Researchers follow up and record the patient's medication status and adverse reactions in the medication process by phone or WeChat, and evaluate patient compliance. Record the eradication rate. Compare the eradication rate, the incidence of adverse reactions, and the compliance of the patients before and after the training of the gastroenterologists.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 2000
• Est. completion date: September 2022
• Est. primary completion date: September 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• 1.Physician specialized in gastroenterology.

• 2.Diagnosis and treatment conditions for H. pylori exist in the hospital where the gastroenterology doctor is located.

(C13 urea breath test, C14 urea breath test, rapid urease test, stool H. pylori antigen test, histopathological test, H. pylori culture, any of the above)

Exclusion Criteria:

• 1.Those who are unable or unwilling to provide informed consent.

• 2.Patients with H. pylori have never been diagnosed and treated.

Related Conditions & MeSH terms

• Helicobacter Pylori Infection

Intervention

Behavioral:
• Standardized training on Helicobacter pylori eradication treatment
Standardized training on Helicobacter pylori eradication treatment

Locations

Country	Name	City	State
China	Xiuli Zuo	Jinan	Shandong

Sponsors (1)

Lead Sponsor	Collaborator
Shandong University

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Eradication rate	The eradication rate of before and after the gastroenterologists receiving standardized Helicobacter pylori eradication training	1 year